Investors

Overview

Overview

Harnessing the power of the immune system to treat cancer and other diseases.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cells therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cell, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response and improve persistence for durable activity in patients.